Canada Life’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Canada Life’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-489	Closed	-$26K	–	2685
2020 Q3	$26K	Hold	489	–	–	﹤0.01%	2382
2020 Q2	$30K	Hold	489	–	–	﹤0.01%	2405
2020 Q1	$27K	Hold	489	–	–	﹤0.01%	2315
2019 Q4	$28K	Buy	+489	New	+$25.9K	﹤0.01%	2432
2019 Q3	–	Sell	-922	Closed	-$55K	–	2623
2019 Q2	$55K	Buy	+922	New	+$58K	﹤0.01%	2416
2019 Q1	–	Sell	-922	Closed	-$54K	–	2730
2018 Q4	$54K	Buy	+922	New	+$55.1K	﹤0.01%	2345

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Canada Life's BSTC Position: Q4 2020 in Review

Canada Life sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 489 shares — an estimated $26K sold.

Canada Life first reported a position in BSTC in Q4 2018 and held it in 6 quarters. The position peaked at $55K in Q2 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Canada Life reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Canada Life sold 489 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $26K.
Canada Life first reported a position in BioSpecifics Technologies Corp. in Q4 2018 and held it in 6 quarters.
Canada Life's BioSpecifics Technologies Corp. position peaked at $55K in Q2 2019.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Canada Life's 13F filing for Q4 2020, filed 16 Feb 2021.